$MMSI (Merit Medical Systems, Inc.)

$MMSI {{ '2016-07-06T16:00:23+0000' | timeago}} • Announcement

$MMSI said it has acquired DFINE, headquartered in San Jose, California, in a merger transaction through which DFINE has become a wholly-owned subsidiary of $MMSI. The purchase consideration was about $97.5MM in cash and was financed by a group of banks led by Wells Fargo and included Bank of America, HSBC and U.S. Bank.

$ABT {{ '2017-10-20T18:04:31+0000' | timeago}} • Webcast

$ABT stated that regarding Alere, the company expects it to contribute around $475MM to its reported sales in FY17 and forecasts a neutral impact on adjusted EPS for the year. For FY17, $ABT continues to forecast comparable operational sales growth in the mid-single digits.

$ABT {{ '2017-10-20T17:56:19+0000' | timeago}} • Webcast

$ABT continues to anticipate CE Mark for its Alinity molecular diagnostic systems in the coming months and expect to begin the launch of the Alinity instruments in the US in 2018. In nutrition business outside China, the company expects to see soft market conditions across few international markets.

$ISRG {{ '2017-10-19T21:40:26+0000' | timeago}} • Announcement

Worldwide da Vinci procedures grew approx. 15% in 3Q17 as $ISRG shipped 169 da Vinci Surgical Systems during the quarter. With $TRXC already in its sight, Intuitive Surgical will also be eyeing $MDT with much more concern as Medtronic is set to roll out its surgical robot system next year.

$NUVA {{ '2017-10-19T12:36:06+0000' | timeago}} • Announcement

$NUVA announced the launch of Modulus XLIF titanium implants. The new Modulus titanium implants are developed using additive manufacturing technology, or 3D printing, to create an organic, porous architecture that mimics the porosity and stiffness of bone for reduced stress shielding.

$ABT {{ '2017-10-18T18:04:16+0000' | timeago}} • Announcement

$ABT narrowed its FY17 EPS outlook range, which continues to reflect double-digit growth. The company now expects GAAP EPS to be $0.97-0.99 for FY17, while adjusted diluted EPS is now expected in the range of $2.48-2.50, which represents an increase at the mid-point of the guidance range. For 4Q17, $ABT expects EPS to be $0.28-$0.30.

$ABT {{ '2017-10-18T17:33:26+0000' | timeago}} • Announcement

$ABT swung to profit in 3Q17 on higher device sales and benefits from St. Jude Medical acquisition. Strength in medical devices business helped the company post a profit of $603MM or $0.32 per share from a loss of $329MM or $0.24 per share a year ago. Net sales jumped 28.8% to $6.8Bil, with adjusted EPS climbing 12% to $0.66 per share.

$ABBV {{ '2017-10-18T16:05:30+0000' | timeago}} • Announcement

$ABBV and Harpoon Therapeutics, a biotechnology company developing novel T-cell recruiting biologic therapies, announced that they have entered an immuno-oncology research collaboration.

$ABT {{ '2017-10-18T13:13:48+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q3 2017 Highlights

$MASI {{ '2017-10-16T21:02:15+0000' | timeago}} • Announcement

$MASI announced that the bankruptcy court in San Diego has issued final judgment holding that Sotera Wireless Employees misappropriated Masimo trade secrets. The misappropriation stems from two former Masimo employees, James Welch and David Hunt, copying thousands of confidential Masimo documents and using Masimo’s trade secrets to benefit Sotera.

$MDT {{ '2017-10-16T20:09:05+0000' | timeago}} • Announcement

$MDT said its Medtronic Care Management Services (MCMS) business and American Well entered into a strategic partnership. Under the agreement, the businesses will work together to enable patient access to American Well's telemedicine services on MCMS' video-enabled platforms, and to allow bi-directional data flow between the two parties.

$NUVA {{ '2017-10-16T13:28:28+0000' | timeago}} • Announcement

$NUVA has received an expanded FDA 510(k) clearance of its TLX interbody system, used in spinal fusion surgery. New clearance introduces an expandable 20 degree cage and broader indications for use.

$CRY {{ '2017-10-10T21:57:05+0000' | timeago}} • Announcement

In connection with the JOTEC transaction, $CRY has terminated its relationship with some of its distributors. Due to this, $CRY will buy back a portion of the inventory previously sold to these distributors, which will result in a $1.1MM reversal of revenues. Considering this and aforementioned factors, preliminary 3Q17 revenues were approx. $44MM.

$CRY {{ '2017-10-10T21:56:48+0000' | timeago}} • Announcement

$CRY said 3Q17 revenues were adversely affected due to the impact of the recent hurricanes on its business in Florida and Texas, which is estimated to be approx. $1MM, and additionally due to the continued delay in obtaining the re-certification of AAP. Including the impact of these factors, 3Q17 revenue was approx. $45.1MM.

$CRY {{ '2017-10-10T21:56:25+0000' | timeago}} • Announcement

$CRY will acquire JOTEC AG. $CRY expects the acquired portfolio to post double-digit growth outside the US for at least the next five years. The deal will also drive GM expansion and help deliver 20% or higher operating margins. $CRY believes it will be able to deliver adjusted EPS growth at a CAGR of at least 20% over the next five years.

$CRY {{ '2017-10-10T21:56:09+0000' | timeago}} • Announcement

$CRY has agreed to acquire German-based company JOTEC AG for $225MM, consisting of 75% in cash and 25% in CryoLife common stock issued to JOTEC's shareholders. $CRY expects to finance the transaction as well as refinance its existing $69MM term loan, with new $255MM senior secured credit facilities. The deal is expected to close later in 2017.

$LIVN {{ '2017-10-09T12:48:05+0000' | timeago}} • Announcement

$LIVN said it has received US FDA approvals for its latest Vagus Nerve Stimulation Therapy System, which consists of the SenTiva implantable generator and the next-generation VNS Therapy Programming System for the treatment of patients with drug-resistant epilepsy.

$MMM {{ '2017-10-05T19:53:45+0000' | timeago}} • Announcement

$MMM announced the early tender results of its previously announced tender offers to purchase for cash up to $400MM aggregate principal amount of its 5.70% notes due 2037 and 6.375% debentures due 2028. The company said it has exercised its option to have an early settlement date on Oct. 6, 2017

$JNJ {{ '2017-10-05T13:58:49+0000' | timeago}} • Announcement

Animas Corp., a $JNJ Diabetes Care Companies, plans to discontinue the manufacturing and sale of Animas Vibe and OneTouch Ping insulin pumps, close operations and exit the insulin pump business. Animas has selected $MDT as its partner-of-choice to facilitate a seamless transition for patients, caregivers and healthcare providers.

$HRC {{ '2017-10-05T12:06:47+0000' | timeago}} • Announcement

Chairman of $HRC Board Rolf Classon will not stand for re-election to the BoD when his current term expires on March 6, 2018. The Board plans to appoint current independent director William Dempsey to this role if he is re-elected by shareholders. The company also elected Gary Ellis, retired CFO and SVP of $MDT, to its BoD, effective Oct 5, 2017.

$JCI {{ '2017-10-05T11:28:33+0000' | timeago}} • Announcement

$JCI has completed the previously announced sale of its Scott Safety business to $MMM for approx $2Bil. Net cash proceeds from the transaction were $1.9Bil, and will be used to repay a portion of Tyco International Holding Sarl's $4Bil of merger-related debt.

Recent Transcripts

NURO (NeuroMetrix Inc.)
Thursday, October 19 2017 - 12:00pm
ABT (Abbott Laboratories)
Wednesday, October 18 2017 - 1:00pm
MDT (Medtronic plc)
Tuesday, August 22 2017 - 12:00pm
TEAR (TearLab Corporation)
Monday, August 14 2017 - 8:30pm
LIVN (LivaNova PLC)
Wednesday, August 9 2017 - 1:00pm
ZGNX (Zogenix, Inc.)
Tuesday, August 8 2017 - 8:30pm
XNCR (Xencor, Inc.)
Monday, August 7 2017 - 8:30pm
OFIX (Orthofix International N.V.)
Monday, August 7 2017 - 8:30pm
AET (Aetna Inc.)
Thursday, August 3 2017 - 12:30pm
SRDX (SurModics, Inc.)
Thursday, August 3 2017 - 12:30pm
OSUR (OraSure Technologies, Inc.)
Wednesday, August 2 2017 - 9:00pm
MASI (Masimo Corporation)
Wednesday, August 2 2017 - 8:30pm
WMGI (Wright Medical Group N.V.)
Wednesday, August 2 2017 - 8:30pm
ZIOP (ZIOPHARM Oncology, Inc.)
Monday, July 31 2017 - 8:30pm
ABBV (AbbVie Inc.)
Friday, July 28 2017 - 1:00pm
ITGR (Integer Holdings Corporation)
Thursday, July 27 2017 - 9:00pm
TNDM (Tandem Diabetes Care, Inc.)
Thursday, July 27 2017 - 8:30pm
SYK (Stryker Corporation)
Thursday, July 27 2017 - 8:30pm
NUVA (NuVasive, Inc.)
Thursday, July 27 2017 - 8:30pm
MMSI (Merit Medical Systems, Inc.)
Wednesday, July 26 2017 - 9:00pm

AlphaGraphics you may like